Virus-based gene therapy strategies for bone regeneration.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biomaterials

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1016/J.BIOMATERIALS.2006.07.032PMID 16928397
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dermal Fibroblasts Genetically Modified to Express Runx2/Cbfa1 as a Mineralizing Cell Source for Bone Tissue Engineering

  2007cited by this paper
• Ca[2+] handing in cardiomyocytes

  2007cited by this paper
• Adenoviral vectors

  2006cited by this paper
• Inducible regulation of Runx2-stimulated osteogenesis

  2006cited by this paper
• Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells.

  2006cited by this paper
• Effect of BMP-2 gene transfer on bone healing in sheep

  2006cited by this paper
• Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation

  2006cited by this paper
• Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene.

  2006cited by this paper
• Pharmacologic transgene control systems for gene therapy

  2006cited by this paper
• Gene Therapy Progress and Prospects – Vectorology: design and production of expression cassettes in AAV vectors

  2006cited by this paper
• Mineralization capacity of Runx2/Cbfa1-genetically engineered fibroblasts is scaffold dependent.

  2006cited by this paper
• Effects of Runx2 genetic engineering and in vitro maturation of tissue-engineered constructs on the repair of critical size bone defects.

  2006cited by this paper
• Different Osteogenic Potentials of Recombinant Human BMP-6 Adeno-Associated Virus and Adenovirus in Two Rat Strains

  2006cited by this paper
• Tissue-Engineered Bone from BMP-2–Transduced Stem Cells Derived from Human Fat

  2005cited by this paper
• Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo.

  2005cited by this paper
• [Functions of BMPs, Runx2, and osterix in the development of bone and cartilage].

  2005cited by this paper
• Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy

  2005cited by this paper
• Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo.

  2005cited by this paper
• Regulatable gene expression systems for gene therapy applications: progress and future challenges.

  2005cited by this paper
• Healing of Critically Sized Femoral Defects, Using Genetically Modified Mesenchymal Stem Cells from Human Adipose Tissue

  2005cited by this paper
• Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo.

  2005cited by this paper
• Tissue engineering strategies for bone regeneration.

  2005cited by this paper
• Bone reconstruction: from bioceramics to tissue engineering

  2005cited by this paper
• Relationship between retroviral DNA-integration-site selection and host cell transcription.

  2005cited by this paper
• Combinatorial gene therapy for bone regeneration: Cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7

  2005cited by this paper
• Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4.

  2005cited by this paper
• Role of Adult Mesenchymal Stem Cells in Bone Tissue Engineering Applications: Current Status and Future Prospects

  2005cited by this paper
• Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2.

  2005cited by this paper
• Gutless adenovirus: last-generation adenovirus for gene therapy

  2005cited by this paper
• Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors – design, biosafety, and production

  2005cited by this paper
• Retroviral gene therapy: safety issues and possible solutions.

  2005cited by this paper
• Novel Starch-Based Scaffolds for Bone Tissue Engineering: Cytotoxicity, Cell Culture, and Protein Expression

  2004cited by this paper
• Gene Therapy Progress and Prospects: Electroporation and other physical methods

  2004cited by this paper
• Runx2/Cbfa1‐genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro

  2004cited by this paper
• Adenoviral Vectors for Gene Replacement Therapy

  2004cited by this paper
• Adenovirus vectors: biology, design, and production.

  2004cited by this paper
• Synergy between Genetic and Tissue Engineering: Runx2 Overexpression and in Vitro Construct Development Enhance in Vivo Mineralization

  2004cited by this paper
• Lentiviral vectors: optimization of packaging, transduction and gene expression

  2004cited by this paper
• Regional gene therapy to enhance bone repair

  2004cited by this paper
• Retroviral vectors: new applications for an old tool

  2004cited by this paper
• Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation.

  2004cited by this paper
• Short‐Term BMP‐2 Expression Is Sufficient for In Vivo Osteochondral Differentiation of Mesenchymal Stem Cells

  2004cited by this paper
• Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system.

  2004cited by this paper
• Exogenous Runx2 Expression Enhances in Vitro Osteoblastic Differentiation and Mineralization in Primary Bone Marrow Stromal Cells

  2004cited by this paper
• Gene Therapy Approaches for Bone Regeneration

  2004cited by this paper
• Current strategies for cell delivery in cartilage and bone regeneration.

  2004cited by this paper
• Controlled release systems for DNA delivery.

  2004cited by this paper
• Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype.

  2004cited by this paper
• Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery

  2004cited by this paper
• Local application of basic fibroblast growth factor into the bone increases bone mass at the applied site in rabbits

  2004cited by this paper
• Construction of a retroviral vector production system with the minimum possibility of a homologous recombination

  2003cited by this paper
• The role of cell type in bone healing mediated by ex vivo gene therapy

  2003cited by this paper
• Gene therapy to improve osteogenesis in bone lesions with severe soft tissue damage

  2003cited by this paper
• Adeno-associated virus integrates site-specifically into human chromosome 19 in either orientation and with equal kinetics and frequency.

  2003cited by this paper
• BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2.

  2003cited by this paper
• Functional Cooperativity Between Osteoblast Transcription Factors: Evidence for the Importance of Subnuclear Macromolecular Complexes?

  2003cited by this paper
• Comparison of Multi-Lineage Cells from Human Adipose Tissue and Bone Marrow

  2003cited by this paper
• In vivo bone formation in fracture repair induced by direct retroviral-based gene therapy with bone morphogenetic protein-4.

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• Human Mesenchymal Stem Cells Transduced with Recombinant Bone Morphogenetic Protein-9 Adenovirus Promote Osteogenesis in Rodents

  2003cited by this paper
• Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect.

  2003cited by this paper
• Initiation of Smad-Dependent and Smad-Independent Signaling via Distinct BMP-Receptor Complexes

  2003cited by this paper
• In Vitro and In Vivo Synergistic Interactions Between the Runx2/Cbfa1 Transcription Factor and Bone Morphogenetic Protein‐2 in Stimulating Osteoblast Differentiation

  2003cited by this paper
• Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs) 1 1 J Bone Joint Surg Am 2003;85A:1544–52

  2003cited by this paper
• Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.

  2003cited by this paper
• Mechanism of Bone Formation with Gene Transfer of the cDNA Encoding for the Intracellular Protein LMP-1

  2003cited by this paper
• Bone induction by BMP‐2 transduced stem cells derived from human fat

  2003cited by this paper
• A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis

  2003cited by this paper
• Evaluation of risks related to the use of adeno-associated virus-based vectors.

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-β family signalling

  2003cited by this paper
• Control of osteoblast function and regulation of bone mass

  2003cited by this paper
• Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).

  2003cited by this paper
• Effect of Regional Gene Therapy with Bone Morphogenetic Protein-2-Producing Bone Marrow Cells on Spinal Fusion in Rats

  2003cited by this paper
• Progress and prospects: naked DNA gene transfer and therapy

  2003cited by this paper
• Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2.

  2003cited by this paper
• Bone morphogenetic protein‐2 enhances osterix gene expression in chondrocytes

  2003cited by this paper
• Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats

  2003cited by this paper
• Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells.

  2003cited by this paper
• In Vivo Evaluation of Gene Therapy Vectors in Ex Vivo-Derived Marrow Stromal Cells for Bone Regeneration in a Rat Critical-Size Calvarial Defect Model

  2003cited by this paper
• Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors

  2003cited by this paper
• Regulation of the osteoblast‐specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways

  2003cited by this paper
• BMP-2-induced Runx2 Expression Is Mediated by Dlx5, and TGF-β1 Opposes the BMP-2-induced Osteoblast Differentiation by Suppression of Dlx5 Expression*

  2003cited by this paper
• Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes

  2003cited by this paper
• Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation.

  2003cited by this paper
• Rat strain differences in the ectopic osteogenic potential of recombinant human BMP adenoviruses.

  2003cited by this paper
• Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type

  2003cited by this paper
• Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration

  2003cited by this paper
• A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis.

  2003cited by this paper
• Blocking endogenous FGF-2 activity prevents cranial osteogenesis.

  2002cited by this paper
• Integration site selection by lentiviruses: biology and possible control.

  2002cited by this paper
• Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

  2002cited by this paper
• The role of the osteoconductive scaffold in synthetic bone graft.

  2002cited by this paper
• Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer.

  2002cited by this paper
• Bone-grafting and bone-graft substitutes.

  2002cited by this paper
• Bone Morphogenetic Protein-Transduced Human Fibroblasts Convert to Osteoblasts and Form Bone in Vivo

  2002cited by this paper
• In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy

  2002cited by this paper
• Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4.

  2002cited by this paper
• Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.

  2002cited by this paper
• Cell‐Type‐Dependent Up‐Regulation of In Vitro Mineralization After Overexpression of the Osteoblast‐Specific Transcription Factor Runx2/Cbfa1

  2002cited by this paper
• BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice.

  2002cited by this paper

• Biomaterial-assisted gene therapy for bone repair.

  2026cites this paper
• Investigation of the properties of osteoplastic matrices composed of polylactide microparticles and platelet-rich plasma, impregnated with adenoviral vectors encoding the BMP2 gene

  2025cites this paper
• Advances in harnessing biological macromolecules for periodontal tissue regeneration: A review.

  2025cites this paper
• Antisolvent 3D Printing of Gene-Activated Scaffolds for Bone Regeneration

  2024cites this paper
• An Optimized Protocol of Electroporation of Hepatocyte Nuclear Factor 1 Alpha (Hnf-1α) in Mesenchymal Stem Cells

  2024cites this paper
• Sema3A Modified PDLSCs Exhibited Enhanced Osteogenic Capabilities and Stimulated Differentiation of Pre-Osteoblasts

  2023cites this paper
• CRISPR/Cas9 correction of a dominant cis‐double‐variant in COL1A1 isolated from a patient with osteogenesis imperfecta increases the osteogenic capacity of induced pluripotent stem cells

  2023cites this paper
• Scaffolds as Carriers of Drugs and Biological Molecules for Bone-Tissue Bioengineering

  2022cites this paper
• Mesenchymal stem cells overexpressing BMP-9 by CRISPR-Cas9 present high in vitro osteogenic potential and enhance in vivo bone formation

  2021cites this paper
• TREATMENT POSSIBILITIES FOR ACQUIRED AND HEREDITARY DISEASES BY GENE THERAPY: A REVIEW

  2021influential citation
• The Future of Regenerative Medicine

  2020cites this paper
• Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications

  2020cites this paper
• Regenerative Medicine for Spine and Joint Pain

  2020cites this paper
• Gene delivery into cells and tissues

  2020cites this paper
• Biological bone tissue engineering with adipose stem cell combined gene therapy: A future prospect in treating oral peri-implant defects

  2020cites this paper
• Thermoresponsive Injectable Microparticle-Gel Composites with Recombinant BMP-9 and VEGF Enhance Bone Formation in Rats.

  2019cites this paper
• BMP-2 Gene Delivery-Based Bone Regeneration in Dentistry

  2019cites this paper
• Gene Delivery Therapeutics in the Treatment of Periodontitis and Peri-Implantitis: A State of the Art Review

  2019influential citation
• Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone

  2019cites this paper
• In vitro evaluation of a lentiviral two-step transcriptional amplification system using GAL4FF transactivator for gene therapy applications in bone repair

  2018cites this paper
• Histone-targeted gene transfer of bone morphogenetic protein-2 enhances mesenchymal stem cell chondrogenic differentiation.

  2018cites this paper
• A bone-targeting drug-delivery system based on Semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice.

  2018cites this paper
• Gene Therapy Strategies in Bone Tissue Engineering and Current Clinical Applications.

  2018cites this paper
• miR-29b-Loaded Gold Nanoparticles Targeting to the Endoplasmic Reticulum for Synergistic Promotion of Osteogenic Differentiation.

  2016cites this paper
• Bone scaffolds: What's new in nanoparticle drug delivery research?

  2016cites this paper
• Delivery systems for biopharmaceuticals. Part II: Liposomes, Micelles, Microemulsions and Dendrimers.

  2015cites this paper
• Mesenchymal stem cells expressing baculovirus-engineered BMP-2 and VEGF enhance posterolateral spine fusion in a rabbit model.

  2015cites this paper
• Cartilage Tissue Engineering: Recent Advances and Perspectives from Gene Regulation/Therapy

  2015cites this paper
• VEGF therapeutic gene delivery using dendrimer type bio-reducible polymer into human mesenchymal stem cells (hMSCs).

  2015cites this paper
• Preclinical Safety Evaluation of ASCs Engineered by FLPo/Frt-Based Hybrid Baculovirus: In Vitro and Large Animal Studies

  2015cites this paper
• Novel MesoPorous BioGlass/silk scaffold containing adPDGF-B and adBMP7 for the repair of periodontal defects in beagle dogs.

  2015cites this paper
• Investigation of Parameters Affecting the Nanoinjection of HeLa 229 Cancer Cells

  2015cites this paper
• Gene transfer vectors (DNA vehicles) and their incorporation into biomaterials for bone repair

  2014cites this paper
• Spatiotemporal Genetic Control of Cellular Systems

  2014cites this paper
• Nucleic Acids Delivery Systems: A Challenge for Pharmaceutical Technologists.

  2014cites this paper
• The root canal system: A channel through which we can seed cells into grafts

  2014cites this paper
• A Comparative Study of Non-Viral Gene Delivery Techniques to Human Adipose-Derived Mesenchymal Stem Cell

  2014cites this paper
• Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b.

  2014cites this paper
• Isolation and characterization of the human immature osteoblast culture system from the alveolar bones of aged donors for bone regeneration therapy

  2014cites this paper
• Effect of the human insulin-like growth factor 1 gene transfection to human umbilical cord blood mesenchymal stem cells.

  2014cites this paper
• Drug delivery in aortic valve tissue engineering.

  2014cites this paper
• Essential Biomaterials Science

  2014cites this paper
• Characterization of Genetically Modified HUCPVCs as an Osteogenic Cell Source.

  2014influential citation
• A Brief Review of Viral Delivery Systems for Bone Tissue Engineering

  2014cites this paper
• Gene Therapy for Bone Tissue Engineering

  2014cites this paper
• Chemically tunable cationic polymer-bonded magnetic nanoparticles for gene magnetofection.

  2014cites this paper
• Viral Gene Therapy Vectors

  2014cites this paper
• Bone and Cartilage Tissue Engineering

  2014cites this paper
• The angiopoietin:Tie 2 interaction: a potential target for future therapies in human vascular disease.

  2013cites this paper
• The role of miR-31-modified adipose tissue-derived stem cells in repairing rat critical-sized calvarial defects.

  2013cites this paper
• Biodistribution and in vivo efficacy of genetically modified human mesenchymal stem cells systemically transplanted into a mouse bone fracture model

  2013cites this paper
• Nanotechnology for Regenerative Medicine

  2013cites this paper
• Enhancement of bone formation by genetically engineered human umbilical cord-derived mesenchymal stem cells expressing osterix.

  2013cites this paper
• Prospects of Gene Therapy

  2013cites this paper
• Chapter 13 – Engineered Proteins for Controlling Gene Expression

  2013cites this paper
• Efficacy of mesoporous silica nanoparticles in delivering BMP-2 plasmid DNA for in vitro osteogenic stimulation of mesenchymal stem cells.

  2013cites this paper
• The role of surface functionalization of colloidal alumina particles on their controlled interactions with viruses.

  2013cites this paper
• Recent progresses in gene delivery-based bone tissue engineering.

  2013cites this paper
• Adenovirus encoding BMP-7 immobilized on titanium surface exhibits local delivery ability and regulates osteoblast differentiation in vitro.

  2013cites this paper
• Biodistribution and in vivo efficacy of genetically modified human mesenchymal stem cells systemically transplanted into a mouse bone fracture model

  2013cites this paper
• Strategies for controlled delivery of growth factors and cells for bone regeneration.

  2012cites this paper
• Augmented healing of critical-size calvarial defects by baculovirus-engineered MSCs that persistently express growth factors.

  2012cites this paper
• Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

  2012cites this paper
• Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction

  2012cites this paper
• Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects.

  2012cites this paper
• The Potential of Tissue Engineering and Regeneration for CraniofacialBone

  2012cites this paper
• Understanding the in vitro dissolution rate of glasses with respect to future clinical applications

  2012cites this paper
• Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles

  2012cites this paper
• Biodegradation of Calcium Phosphate Cement Composites

  2012cites this paper
• Overexpression of GDF5 through an Adenovirus Vector Stimulates Osteogenesis of Human Mesenchymal Stem Cells in vitro and in vivo

  2012cites this paper
• Nonviral gene delivery of erythropoietin by mesenchymal stromal cells

  2011cites this paper
• Electroporation-mediated transfer of Runx2 and Osterix genes to enhance osteogenesis of adipose stem cells.

  2011cites this paper
• Biomolecular strategies of bone augmentation in spinal surgery.

  2011cites this paper
• Bone and Cartilage from Stem Cells: Growth Optimalization and Stabilization of Cell Phenotypes

  2011cites this paper
• Cell- and gene-based therapeutic strategies for periodontal regenerative medicine.

  2011cites this paper
• Transcription factor osterix modified bone marrow mesenchymal stem cells enhance callus formation during distraction osteogenesis.

  2011cites this paper
• Bioactive materials in gene therapy

  2011cites this paper
• Engineered Proteins for Controlling Gene Expression

  2011cites this paper
• 5.510 – Engineered Bioactive Molecules

  2011cites this paper
• Chondrogenesis of adipose stem cells in a porous PLGA scaffold impregnated with plasmid DNA containing SOX trio (SOX-5,-6 and -9) genes.

  2011cites this paper
• Future approaches in periodontal regeneration: gene therapy, stem cells, and RNA interference.

  2010cites this paper
• Enhancing Allograft Bone Healing Through Gene Therapy

  2010cites this paper
• Platelet-Derived Growth Factor Delivery via Nanofibrous Scaffolds for Soft-Tissue Repair.

  2010cites this paper
• Effect of strontium ions substitution on gene delivery related properties of calcium phosphate nanoparticles

  2010cites this paper
• The effects of Runx2 immobilization on poly (epsilon-caprolactone) on osteoblast differentiation of bone marrow stromal cells in vitro.

  2010cites this paper
• An investigation of poly(caprolactone-co-glycolide) interaction with bioactive proteins and cellular responses

  2010cites this paper
• Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells.

  2010cites this paper
• The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells.

  2010cites this paper
• Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells.

  2010cites this paper
• Gene Therapy and its Implications in Dentistry

  2010cites this paper
• Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells.

  2010cites this paper
• Genetische Modifikationen Mesenchymaler Stromazellen des Knochenmarks und deren regeneratives Potential im Schlaganfallmodell

  2010cites this paper
• Baculovirus as a gene delivery vector for cartilage and bone tissue engineering.

  2010cites this paper
• Computational and Theoretical Concepts for Regulating Stem Cells Using Viral and Physical Methods

  2010cites this paper
• Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells)

  2009cites this paper
• Novel regenerative strategies to enhance periodontal therapy outcome

  2009cites this paper
• Dental Hard Tissue Engineering

  2009cites this paper
• Transcutaneous immunization by lipoplex-patch based DNA vaccines is effective vaccination against Japanese encephalitis virus infection.

  2009cites this paper
• Baculovirus transduction of chondrocytes elicits interferon‐α/β and suppresses transgene expression

  2009cites this paper
• AAV Based Ex Vivo Gene Therapy in Rabbit Adipose-derived Mesenchymal Stem/Progenitor Cells for Osteogenesis

  2009cites this paper